Equities

IFR US ECM PRICINGS

| Robert Sherwood

Carlsmed (US, medical devices) ─ $100.5m IPO. 6.7m shares (Primary) at $15.00 versus $14-$16 marketing. BOFA, GS, PS. Nasdaq "CARL". Backed with $31m of upfront demand from B Capital Group and U.S. Venture Partners.

NIQ Global Intelligence (US, market research) ─ $1.05bn IPO. 50m shares (Primary) at $21.00 versus $20-$24 marketing. JPM, BOFA, UBS, BARC, RBC. NYSE “NIQ”. Advent International is providing shares for the greenshoe. 5% DSP.

Pharvaris (Netherlands, biotech) ─ $175m ABB. 8.8m shares (Primary) at $20.00 fixed price versus $23.12 last sale. MS, LEER, OPCO, CANT, VLK. Upsized from $150m.

Topics

Americas Equity Capital North America United States Initial Public Offerings (IPO) Marketed Follow-Ons US Dollar ABBs and Block Trades Europe, Middle East and Africa Europe Western Europe Netherlands

Issuers

Carlsmed Inc (CARL.OQ) NIQ Global Intelligence PLC Pharvaris NV (PHVS.O)